Print this article
- 11/22/2016

Bioenergy Ribose – The science behind the powerful energy ingredient

AgroFOOD Industry Hi Tech

Bioenergy Ribose® is a unique 5 carbon carbohydrate that can be used as a standalone product or added to a variety of functional foods, beverages, and nutraceuticals. It is natural, safe and clinically proven.

Bioenergy Ribose MoleculeRibose is the vital structural backbone of critical cellular compounds called purines and pyrimidines. Our bodies must have an adequate supply of purines and pyrimidines to form major cellular constituents such as our genetic material (DNA and RNA), numerous cofactors and certain vitamins. But more importantly, ribose is the backbone of adenosine triphosphate (ATP)—the source for all cellular energy. Ribose is the starting point and the rate limiting compound in the synthesis of these fundamental cellular compounds and the availability of ribose determines the rate at which they can be made by our cells and tissues.

Bioenergy Ribose is unique in this metabolic role. No other compound can replace ribose in the important job of regulating the metabolic processes involved in synthesizing purines and pyrimidines. And without these vital structural components, our bodies would quickly run out of energy, could not make proteins and our cells would lose the ability to replicate. Energy recovery and tissue repair are slower in heart and muscle cells, especially after overwork or exercise. Ribose drives the process that replenishes ATP and other energy components in these cells.

Ribose is made in our bodies’ cells from glucose, but this process is slow in heart and muscle tissue. Although ribose is present in all living matter, only a small amount can be ingested through the diet. In many U.S. and European clinical studies, providing supplemental Bioenergy Ribose has been shown to significantly improve endurance during strenuous exercise, shorten recovery time, reduce cramping and soreness, and reduce fatigue in people suffering from energy depletion. View a sampling of these clinical studies.

Stand No: J32